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Defective regulation of insulin release and transmembrane Ca2" fluxes by
human islet cell tumours
P.R. Flatt, S.K. Swanston-Flatt, C.J. Powell & V. Marks
Department ofBiochemistry, University ofSurrey, Guildford, Surrey GU2 5XH, UK.
Summary Regulation of insulin release and transmembrane Ca2 + fluxes was examined using pieces of 3
benign medullary-type insulinomas removed from the pancreas of female patients at surgery. Immuno-
cytochemical staining confirmed the presence of insulin-containing cells with no demonstrable glucagon,
somatostatin or pancreatic polypeptide. After 3 days of culture in RPMI-1640, tumour pieces released
11-158mg insulin kg-' dry wt during acute 60min incubations with the concomitant uptake of 2-47mmol
45Cakg- 1 into the intracellular lanthanum-nondisplaceable pool. At 2.56 mm Ca2 +, glucose alone or in
combination with glyceraldehyde, mannoheptulose or diazoxide did not modify insulin release or 45Ca
uptake. Theophylline significantly increased insulin release from 2 tumours with a small stimulatory effect on
the third. A depolarising concentration of K+ enhanced insulin release from one tumour but thi,s was not
associated with an increase of 45Ca uptake. Calcium antagonists, (verapamil, D-600 and trifluoroperazine)
and calcium ionophores (A23187 and Br-X537A) failed to modify insulin release or 45Ca uptake by each of
the two tumours tested. Evaluation of 45Ca efflux from one tumour confirmed the unresponsiveness to
glucose, K+, verapamil and A23187. Prolonged culture of 2 tumours for up to 16 days was associated with
the gradual decline of insulin release to a steady output of 2-15ng 24h-1. Addition of verapamil to the
cultures inhibited insulin output from one tumour, but mannoheptulose or diazoxide were without effect. The
results indicate that inappropriate insulin release from these 3 benign medullary-type insulinomas is associated
with disturbances in the regulation of transmembrane Ca2 + fluxes.
During the past decade, considerable evidence has
accumulated concerning the role of metabolic and ionic
events in the regulation of pancreatic B-cell function and
insulin secretion (Hellman et al., 1979; Wollheim & Sharp,
1981; Malaisse, 1983; Henquin & Meissner, 1984). Numerous
studies with rodent islets indicate that nutrient secretogogues
such as glucose are metabolised by the pancreatic B-cells
leading to an increase in cytoplasmic Ca2 + concentration
and the discharge of insulin by exocytosis. Contributions to
cytoplasmic Ca2 + under these circumstances may include
displacement of Ca2 + from intracellular sites such as
mitochondria and endoplasmic reticulum, inhibition of Ca2 +
outward transport across the plasma membrane and
stimulation of Ca2+ entry into the B-cell. Several studies
using human islets support this mechanism (Ashcroft et al.,
1971; Henriksson et al., 1978; Andersson & Hellerstrom,
1980; Grant et al., 1980; Jahr et al., 1983; Harrison et al.,
1985), but analogous studies evaluating defective regulation
of insulin secretion by human insulinomas have not been
performed.
Insulin-secreting tumours (insulinomas) of the pancreas
represent the most common type of enteropancreatic
endocrine cancer in man which without clinical intervention
can result in debilitation and premature death (Frerichs &
Creutzfeldt, 1976; Marks & Rose, 1981; Friesen, 1982; Comi
et al., 1986). Thus despite the relatively low incidence of the
disease (1-2 recognised cases per million of the population
per annum), the diagnosis and treatment of these
heterologous tumours have attracted considerable attention
from pathologists and clinicians. In the present study, we
report the functional and morphological characterisation of
three human benign medullary-type insulinomas. In addition,
we have used small pieces of each tumour maintained in
tissue culture for in vitro studies on the regulation of
transmembrane Ca2 + fluxes, and evaluation of both the
acute and long term effects of nutrients and drugs on insulin
release.
Materials and methods
Clinical histories
Case I The first tumour was obtained from a 60 year old woman
who presented with a 3 year history of 'odd turns' associated with a
sense of unreality. Fasting for 36h coupled with moderate exercise
produced a fall in plasma glucose concentrations to 1.0mm,
associated with pallor and a feeling of tiredness and mild
disorientation. Plasma C-peptide concentrations were consistently
inappropriately elevated (1.2-2.5 pg1- l) during hypoglycaemic
episodes. Plasma insulin concentrations were 5.0-10.0mU 1 At
operation, a 0.8 cm diameter tumour was removed from the head of
the pancreas. The patient has remained well since operation with no
further hypoglycaemic episodes.
Case II The second tumour was obtained from a 45 year old
woman who presented with a 6 year history of 'fits' for which she
had received treatment with anticonvulsant drugs with limited
success. Fasting hypoglycaemia (1.4-1.8mM) with inappropriately
high plasma insulin and C-peptide concentrations (9.6-11.3mUl-1
and 2.3-2.8 g1- 1, respectively) were demonstrated on several
occasions once the correct diagnosis had been suspected. A 1.3cm
diameter tumour was removed from the body of the pancreas at
operation. The patient has since remained well with no recurrence of
hypoglycaemic symptoms.
Case III The third tumour was obtained from a 15 year old girl
who presented with a 12 month history of recurrent episodes of
drowsiness associated with hypoglycaemia (plasma glucose 1.0-
2.0mM). After an overnight fast on 2 consecutive days in hospital,
she became drowsy and plasma glucose concentrations fell to 1.9-
2.2mm. Insulin and C-peptide concentrations at this time were 15.3-
23.3 mU - and 3.5-4.1 pgI-1, respectively. At operation, a small
tumour was removed from the tail of the pancreas. The patient has
remained well since operation and there have been no further
episodes of hypoglycaemia.
Special investigations
In addition to measurements of plasma glucose, insulin and
C-peptide concentrations in the fed and fasted states, various
radiographic and electrophysiological tests were performed.
None provided any additional clinically useful information.
In Cases I and II, glucose tolerance tests were non-
contributory. Oral leucine, i.v. tolbutamide and glucagon
tests were also uninformative, and in particular failed to
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reveal hyperinsulinaemic responses observed in some patients
with insulinoma. These tests were not performed in Case III.
In vitro investigations
Preparation and culture of tumour pieces Immediately after
removal at operation, tumours were placed in tissue culture
medium RPMI-1640 (Gibco Europe Ltd., Paisley, UK)
containing 11.1 mM glucose, 10% foetal calf serum with
added antibiotics (10OUml-1 penicillin and O.lmgml-1
streptomycin; Gibco Europe Ltd., Paisley, UK). The
tumours were transported to the laboratory within 90min of
removal. Using a sterile scalpel blade, the tumours were
chopped into small pieces (25-120 pieces of 100 Mg) and
then maintained in tissue culture for 3 days at 37°C in a
humidified atmosphere of 5% CO2 in air prior to in vitro
tests. Individual tumour pieces were used for only one
experiment as described below.
Acute studies of insulin release and 45Ca uptake Acute
studies of insulin release and 45Ca uptake were conducted
using 3 day cultured pieces of all three tumours. After
rinsing in serum-free culture medium, groups of 2 pieces of
tumour were incubated for 60min at 37°C in a modified
Krebs-Ringer bicarbonate buffer (pH 7.4), containing
20mM N-2-hydroxyethyl-piperazine-N'-2-ethanesulfonic acid
(HEPES), 115mM NaCl, 24mM NaHCO3, 4.7mM KCI,
2.56mM 45CaC12 (7.8 Ci mol- 1; Amersham International
Ltd., Amersham, UK) 1.2mM KH2PO4, 1.2mM MgSO4
and 5 mgml - I bovine serum albumin. Glucose and the
following nutrients and drugs were added at the concentra-
tions given in Tables 1-111: theophylline, glyceraldehyde,
mannoheptulose, K+, diazoxide, verapamil, D-600 (Hoechst,
Milton Keynes, UK), trifluoroperazine (Smith, Kline and
French Laboratories Ltd., Welwyn Garden City, UK),
A23187 (Calbiochem Ltd., San Diego, USA) and Br-X537A
(Hoffman LaRoche and Company Ltd., Basel, Switzerland).
After 60min incubation, aliquots were taken and stored
at -20°C for insulin assay. The tumour pieces were trans-
ferred and washed for 60min at 1°C with 5ml Tris buffer
containing 2mM LaCl3 to remove extracellular and super-
ficial 45Ca prior to measurement of intracellular 45Ca
content (Hellman, 1978). Previous studies have shown that
the 45Ca taken up by connective tissue surrounding islet
cells is removed by La3'-washing (Flatt & Swanson-Flatt,
1985). After freeze-drying overnight and weighing, the
tumour pieces were dissolved in 100M1 Soluene (Packard
Instruments Ltd., Warrenville, USA). After addition of 5ml
Instafluor (Packard), tumour radioactivity was analysed by
liquid scintillation spectrometry. Samples of the labelled
incubation medium (5pl) were used as external standards in
the counting procedure. In the tables, the tumour content
of 45Ca is expressed in terms of millimoles of calcium with
the same specific radioactivity as that of the incubation
medium.
Studies of 45Ca efflux In the case of tumour III, there was
a sufficient number of tumour pieces to enable evaluation of
45Ca efflux in addition to the other parameters. For this
purpose, groups of 2 pieces of tumour (previously cultured
for 3 days) were briefly rinsed and then loaded with 4'Ca
during incubation for 90min in 100Mp of the modified Krebs-
Ringer bicarbonate buffer supplemented with 20mM glucose
and 2.56mM 45Ca (36OCimol-1). After two 5 min washes in
nonradioactive medium containing 3mM glucose, groups of
2 tumour pieces were transferred to 10M, chambers and
perifused for 90 min at a constant rate of
- 40Mi1 minm-
(Flatt et al., 1980). The perifusate was collected over
successive periods of 1 or 5 min, with inclusion of 16.7 mm
glucose, 25mMK SOJUM verapamil or 20Mm A23187 in the
buffer from 35-75 min as indicated in Figures 2 and 3.
Samples of the perifusate (I15 Ml) were mixed with 2 ml
Picofluor- 15 (Packard Instruments Ltd., Warrenville, USA)
and analysed for radioactivity by liquid scintillation
counting. In each individual experiment, the 45Ca efflux rate
(c.p.m.min-1) was expressed as a percentage of the mean
value observed in the same experiment between the 31st and
36th minutes of perifusion.
Long term studies of insulin release Long term studies of
insulin release were performed using pieces of tumour I and
tumour III. After 3 days culture, groups of 2 tumour pieces,
matched for equal size, were cultured in the same type of
medium for an extended period of up to 16 days. Diazoxide
(0.54 mM; Glaxo Group Research, Ware, UK), verapamil
(50pM; Abbot Laboratories Ltd., Queensborough, UK) or
mannoheptulose (15mM; Sigma Chemical Company, Poole,
UK) were included in the culture media from days 3-4
onwards as indicated in Figures 1 and 2. Incubations were
performed at 37°C (pH 7.4) in a gas phase consisting of 5%
CO2 in humidified air. The media were changed at 2-5 day
intervals. In the case of tumour I, the media were removed
at 4, 7, 11 and 14 days. For tumour III, the media were
removed at 3, 6, 8, 13 and 16 days. Aliquots of culture
media removed at these times were stored at -20°C for
insulin assay.
Assays
Plasma glucose was measured by an automated glucose
oxidase procedure (Stevens, 1971). Insulin was determined by
dextran-charcoal radioimmunoassay (Flatt & Bailey, 1981)
using guinea pig anti-porcine insulin antiserum, 1251-bovine
insulin tracer (Amersham International, Amersham, UK)
and human insulin standard (23.5 IUmg-1; WHO
International Laboratory for Biological Standards, London,
UK). C-peptide was measured by double antibody radio-
immunoassay (Hampton & Marks, 1979) using reagents
supplied by Guildhay Antisera (University of Surrey,
Guildford, UK). Parallelism was demonstrated between the
insulin and C-peptide standard curves and serial dilutions of
either plasma or samples arising from the in vitro
investigations. All analyses were performed within 2 weeks
of sample collection.
Histology and immunocytochemistry
Several small pieces of each tumour were fixed for a
minimum of 24h in neutral buffered formalin, dehydrated
through graded ethanols, cleared in toluene and embedded in
paraffin wax for histological and immunocytochemical
investigation. Rehydrated paraffin sections (5gm) were
stained with haematoxylin and eosin, or immunostained by
the indirect immunoperoxidase technique using guinea pig
anti-porcine insulin antiserum (GPB3; PRF/SKS-F), guinea
pig anti-porcine glucagon antiserum (GPC4; Flatt &
Swanston-Flatt, 1981) and affinity purified donkey anti-
guinea pig immunoglobulin G conjugated to horse radish
peroxidase (Guildhay Antisera). Somatostatin and PP were
immunostained by the unlabelled peroxidase anti-peroxidase
(PAP) technique (Sternberger, 1979) using the following
antisera: rabbit anti-cyclic somatostatin (GR21A; Guildhay
Antisera), rabbit and anti-bovine pancreatic polypeptide
(GR39PD; Guildhay Antisera), donkey and anti-rabbit
immunoglobulin G (Guildhay Antisera) and rabbit PAP
complex (Dakopatts, Glostrup, Denmark). Peroxidase acti-
vity was visualised using 3,3'-diaminobenzidine and sections
were lightly counterstained with Harris' haematoxylin.
Control sections were treated with normal serum instead of
the hormone antisera.
Statistical analysis
Values are presented as mean+s.e.m. Statistical evaluation
was performed using Student's paired and unpaired t-test.
Differences were considered to be significant for P<0.05.HUMAN ISLET CELL TUMOURS 461
Results
Histology and immunocytochemistry
At surgery, an adenoma was removed from the pancreas of
each of the patients. This was located in the head, body and
tail of the pancreas for patients I, II and III respectively.
Tumour metastases in the liver or other organs were not
detected, and all patients were still free of hypoglycaemic
symptoms 3-4 years after operation.
Immunocytochemical staining of the 3 tumours (Figure 1)
confirmed the presence of abundant insulin-containing
B-cells with no demonstrable staining for glucagon,
somatostatin or pancreatic polypeptide. The histological
arrangement of cells in each tumour was medullary-type
(group B according to classification by Berger et al., 1983)
with positive insulin immunostaining cells distributed among
negative cells with no polarisation. Tumour I was charac-
terised by an abundant mature fibrous matrix; tumour II was
highly vascularised with evidence of focal mineralisation,
and tumour III was strongly immunostaining and contained
moderate amounts of fibrous connective tissue.
In vitro investigations
Acute studies of insulin release and 45Ca uptake As shown
in Tables I-III, pieces of tumour from the 3 patients released
1 1-158mg insulin kg- 1 dry wt during 60min incubations
with the concomitant intracellular uptake of 2-47mmol
45Cakg-1. Addition of glucose alone or in combination with
glyceraldehyde, mannoheptulose or diazoxide did not modify
insulin release or 4'Ca uptake by any of the tumours, with
the exception of a small increase of 45Ca uptake by pieces of
tumour II exposed to 5.6mM glucose. Addition of
theophylline, increased insulin release from tumours II and
III by 56-77% without affecting 45Ca uptake. A similar
tendency was observed with pieces of tumour I (50%
increase), although this did not achieve statistical significance
because of the scatter of individual values. However, 25mM
K+ stimulated insulin release by 57% from tumour I
without affecting 4'Ca uptake. As indicated by Tables I
and III, the calcium -antagonists verapamil, D-600 and
trifluoroperazine, and the calcium ionophores A23187 and
Br-X537A failed to modify insulin release or 45Ca uptake by
pieces of tumours I and III. These agents were not evaluated
using tumour II due to shortage of tissue.
Studies of 45Ca efflux The effects of glucose, 25mMK,
verapamil and A23187 on 4'Ca efflux following tissue
Table I 45Ca uptake and insulin release by tumour pieces during
acute incubations: Tumour I - located in the head of the pancreas
of a 60 year old woman
Insulin
Glucose 45Ca uptake release
Additions (mM) (mM) (mmolkg-1 h-1) (mgkg-1 h-1)
Nutrients and drugs
None 0 2.08 +0.14 22.94+4.20
None 5.6 2.03 +0.22 23.02+3.20
None 16.7 2.71+0.11 19.32+3.40
Theophylline (5) 16.7 2.33+0.36 38.90+ 16.22
Glyceraldehyde (10) 5.6 3.19+0.82 27.90+2.53
Mannoheptulose (15) 5.6 2.28+0.27 38.92+9.20
KCI (25) 5.6 2.07+0.18 54.14+ 7.20a
Diazoxide (0.54) 5.6 2.14+0.18 29.68+7.34
Calcium antagonists
Verapamil (0.05) 5.6 2.67+0.44 33.88+6.77
D-600 (0.02) 5.6 2.02+0.15 29.05+3.86
Trifluoroperazine (0.02) 5.6 2.09+0.20 29.95+4.31
Calcium ionophores
A23187 (0.02) 5.6 3.42+1.67 37.97+9.02
X537A (25Mgml-1) 5.6 1.85+0.25 34.76+11.01
Groups of 3-day cultured tumour pieces were incubated for 60min
in buffer containing 2.56mM 4"Ca (7.8Cimol-1), 0, 5.6 or 16.7mM
glucose, and the nutrients or drugs as indicated. Radioactivity in
tumour pieces was measured after subsequent washing for 60min
with 2mm LaCl3 at 1°C to remove extracellular and superficially
bound 4"Ca. The amount of intracellular 4'Ca is expressed as mmol
of calcium, assuming the same specific radioactivity as in the
incubation buffer. Values are mean +s.e.m. of 3-4 observations.
ap<0.05 compared with 5.6mm glucose.
preloading with 4'Ca were examined using pieces of tumour
III. As shown in Figures 2 and 3, the 4'Ca efflux rate from
tumour pieces was little affected by addition or removal of
these agents from the perifusion media. This unresponsive-
ness is consistent with the results of acute studies of 4'Ca
uptake (Table III).
Long term studies of insulin release Prolongation of culture
for an extended period of 14-16 days was associated with a
gradual decline of insulin release to steady outputs of
- 15 ng insulin 24h-1 from tumour I (Figure 4) and 2ng
insulin 24h-1 from tumour III (Figure 5) by 4-7 days and
8-13 days, respectively. This progressive decline of insulin
Figure I Immunohistochemical staining for insulin in sections of human tumour. Tumour I (left panel): clumps of strongly
immunostaining cells are closely associated with vascular spaces. Tumour II (middle panel): large numbers of immunostaining cells
are interspersed with vascular tissue. Tumour III (right panel): nests of intensely immunostaining cells are mixed with connective
tissue ( x 313).462 P.R. FLATT et al.
Table II "Ca uptake and insulin release by tumour pieces during
acute incubations: Tumour II - located in the body of the pancreas
of a 45 year old woman
Insulin
Glucose 45Ca uptake release
Additions (mM) (mM) (mmolkg- 1 h-1) mgkg-1 h-1)
Nutrients and drugs
None 0 21.29+4.10 24.94+3.31
None 5.6 37.70+ 1.48a 44.44+ 13.53
None 16.7 23.99+8.57 36.26+4.48
Theophylline (5) 16.7 31.84+10.36 158.41 +52.30ab
Glyceraldehyde (10) 5.6 47.44+ 15.50 70.35+22.92
Mannoheptulose (15) 5.6 29.00+8.27 26.02+2.47
KCl (25) 5.6 36.67+9.58 34.69+0.89
Diazoxide (0.54) 5.6 24.29 +6.76 47.55 + 16.08
Groups of 3-day cultured tumour pieces were incubated for 60min
in buffer containing 2.56mM 4Ca (7.8Cimol 1), 0, 5.6 or 16.7mM
glucose, and the nutrients or drugs as indicated. Radioactivity in
tumour pieces was measured after subsequent washing for 60min
with 2mm LaCl3 at 1°C to remove extracellular and superficially
bound 45Ca. The amount of intracellular 45Ca is expressed as mmol
of calcium, assuming the same specific radioactivity as in the
incubation buffer. Values are mean +s.e.m. of 3-4 observations.
ap<0.001 compared with 0mm glucose; bp<0.05 compared with
16.7mm glucose.
Table III 45Ca uptake and insulin release by tumour pieces during
acute incubations: Tumour III - located in the tail of the pancreas of
a 15 year old girl
Insulin
Glucose 45Ca uptake release
Additions (mM) (mM) (mmolkg-1 h-') (mgkg-1 h-1)
Nutrients and drugs
None 0 6.37+0.58 20.12+5.87
None 5.6 5.68+0.59 17.95+2.67
None 16.7 5.00+0.32 15.34+ 1.07
Theophylline (5) 16.7 6.33 +0.71 35.13+2.26a
Glyceraldehyde (10) 5.6 5.41 +0.13 14.39+2.10
Mannoheptulose (15) 5.6 6.30+0.79 18.90+3.61
KCI (25) 5.6 8.52+2.58 32.95+7.46
Diazoxide (0.54) 5.6 6.67+0.53 11.66+0.97
Calcium antagonists
Verapamil (0.05) 5.6 7.34+0.53 11.99+0.94
D-600 (0.02) 5.6 5.66+0.54 15.74+4.83
Trifluoroperazine (0.02) 5.6 7.03 +0.56 18.92+5.03
Calcium ionophores
A23187 (0.02) 5.6 6.41+0.38 16.74+2.56
X537A (25jigml-1) 5.6 8.45+ 1.23 16.50+ 1.72
Groups of 3-day cultured tumour pieces were incubated for 60min
in buffer containing 2.56mM 45Ca (7.8 Cimol 1), 0, 5.6 or 16.7mM
glucose, and the nutrients or drugs as indicated. Radioactivity in
tumour pieces was measured after subsequent washing for 60min
with 2mm LaCl3 at 1°C to remove extracellular and superficially
bound 45Ca. The amount of intracellular 45Ca is expressed as mmol
of calcium, assuming the same specific radioactivity as in the
incubation buffer. Values are mean + s.e.m. of 3-4 observations.
ap<0.05 compared with 5.6mm glucose.
output is commonly observed during the long term culture of
insulin-secreting cells (Andersson & Hellerstrom, 1980).
Addition of verapamil to the culture medium inhibited
insulin output from pieces of tumour III. In contrast,
diazoxide and mannoheptulose did not affect insulin output
from tumour III, and neither drug affected tumour I. The
demonstration of long term effects of verapamil on tumour
III contrasts with the inability of the drug to acutely depress
insulin release (Table III). This delayed action is suggestive
of a non-specific effect, possibly on cellular insulin stores
(Leinweber & Schatz, 1982).
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Figure 2 Effects of glucose and K+ on 4'Ca efflux from pieces
of tumour III - located in the tail of the pancreas of a 15 year
old girl. Experiments were performed in the parallel channels of
a perifusion apparatus with 3-day cultured tumour pieces loaded
for 90min with 2.56mM 45Ca (360 Cimol-1) in the presence of
20mM glucose. The tumour pieces were perifused with buffer
containing 3mm glucose, with exposure to 16.7mm glucose or
25mM K+during the period from 35-70min, as indicated by the
horizontal bar. Filled symbols signify tumour pieces exposed to
glucose (0) or K+ (-), and open symbols refer to control
tumour pieces (0). Values are mean + s.e.m. of 3 individual
experiments. 45Ca efflux was expressed as a percentage of the
mean value observed in the same experiment between the 31st
and 36th min ofperifusion.
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Figure 3 Effects of verapamil and A23187 on 45Ca efflux from
pieces of tumour III - located in the tail of the pancreas of a 15
year old girl. Experiments were performed in the parallel
channels of a perifusion apparatus with 3-day cultured tumour
pieces loaded for 90min with 2.56mM 45Ca (360Cimol-1) in the
presence of 20mm glucose. The tumour pieces were perifused
with buffer containing 3mM glucose, with exposure to 50/M
verapamil or 20JIM A23187 during the period from 35-70min, as
indicated by the horizontal bar. Filled symbols signify tumour
pieces exposed to verapamil (M) or A23187 (0), and open
symbols refer to control tumour pieces (0). Values are mean
+s.e.m. of 3 individual experiments. 4Ca efflux was expressed
as a percentage of the mean value observed in the same
experiment between the 31st and 36th min ofperifusion.
Discussion
The study of insulin-secreting tumours in man has received
much attention from the morphological, ultrastructural,
diagnostic and therapeutic viewpoints (Frerichs &
Creutzfeldt, 1976; Marks & Rose, 1981; Friesen, 1982; Comi
et al., 1986). However, little attention has been paid to
- §
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biochemistry of insulin secreting tumours in relation to the
underlying secretory defect. Thus, studies performed to date
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Figure 4 Long term studies in insulin release during culture of
pieces of tumour I - located in the head of the pancreas of a 60
year old woman. After 3 days preliminary culture in RPMI-1640
containing 11.1 mM glucose and 10% foetal calf serum, groups of
tumour pieces were cultured in the same type of medium for 14
days. Diazoxide (0.54mM) or verapamil (50yum) were included as
appropriate in the culture media from 4 days onwards as
indicated. The media were changed at 3-4 day intervals. Values
are mean +s.e.m. of 4 observations; Ol control; 3 Diazoxide; U
Verapamil.
have concentrated on the molecular forms of insulin-like
substances produced and mechanisms for insulin degradation
in these cells. The major reason for the paucity of
information is the sporadic incidcnce of the disease, and the
fact that surgical treatment of such patients is restricted to
specialised centres. The present study has made a detailed
investigation of the regulation of insulin release and trans-
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membrane calcium fluxes from pieces of three human
insulinomas obtained at operation. Advantage was taken of
tissue culture to counter effects attributable to prior
hypoglycaemia, and the unavoidable trauma of surgery and
laboratory tissue preparation. This approach also enabled
long-term studies of insulin release and ensured that a
maximum amount of information could be gained from each
tumour.
Although the tumours were derived from distinctly
different regions of the pancreas of patients with a
considerable age span, there were notable similarities of
tumour morphology. Each was classified as a benign
adenoma comprising abundant insulin-staining B-cells with
no demonstable staining for other islet cell hormones
including glucagon, somatostatin and pancreatic polypeptide.
Furthermore, the histological arrangement of the cells
indicates classification as a medullary-type tumour (group B)
with positive insulin immunostaining cells diffusely scattered
throughout the tumour with no polarisation (Berger et al.,
1983). Compared with the in vivo functional characteristics
of the alternative trabecular-type (group A) insulinomas,
tumours such as those evaluated in the present study have
been proposed to display marked unresponsiveness to
modulators of insulin release (Berger et al., 1983). The
present results of acute and long term in vitro tests of insulin
release from each tumour in response to various nutrients
and drugs fully supports this view.
In the present study, it was not feasible to perform parallel
control experiments of insulin release and 45Ca fluxes by
human pancreatic islets. However, the few previous reports
in the literature indicate that knowledge gained from studies
of insulin secretion using rodent islets is almost entirely
applicable to the regulation of insulin release in man
(Ashcroft et al., 1971; Andersson & Hellerstrom, 1980;
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Figure 5 Long term studies of insulin release during culture of pieces of tumour III - located in the tail of the pancreas of a 15
year old girl. After 3 days preliminary culture in RPMI-1640 containing 11.1 mm glucose and 10% foetal calf serum, groups of
tumour pieces were cultured in the same type of medium for 16 days. Diazoxide (0.54mM). mannoheptulose (15urm) or verapamil
(50uM) were included as appropriate in the culture media from 3 days onwards as indicated. The media were changed at 3-5 day
intervals. Values are mean +s.e.m. of 4 observations. *P<0.05 compared with control culture medium; C] control, 0 Diazoxide;
B Mannoheptulose; * Verapamil.
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Henriksson et al., 1978; Grant et al., 1980; Jahr et al., 1983;
Harrison et al., 1985). These studies have not only confirmed
the substrate-specificity and the role of metabolism for
nutrient-induced insulin release but have also highlighted the
role of intracellular messengers such as Ca2 , cyclic AMP
and protein kinases in B-cell stimulus-secretion coupling. The
ineffectiveness of the majority of nutrients and drugs tested
by acute incubation, perifusion or long term culture in the
present study may be cautiously interpreted therefore in
terms of the defect(s) exhibited by the insulinoma cells. It is
not possible to disregard the individual nature of each
tumour, but several general conclusions can be drawn from
the results obtained. Thus, none of the tumours responded
to glucose or glyceraldehyde with stimulated 45Ca uptake
and insulin release. Furthermore, the metabolic inhibitor
mannoheptulose was also without effect. Additional evidence
for defective insulin release and abnormal cellular Ca2+
metabolism concerns the virtual ineffectiveness of a
depolarising concentration of K+ and of diazoxide which are
believed to exert stimulatory and inhibitory effects respec-
tively on the opening of voltage-dependent Ca2+ channels
in the B-cell (Hellman et al., 1979; Wollheim & Sharp,
1981; Henquin & Meissner, 1984). Two established blockers
of this Ca2 + channel (verapamil and D-600) were also
ineffective, as was the intracellular inhibitor of Ca2+-
calmodulin, trifluoroperazine. These observations together
with insensitivity to the Ca2+ ionophores, A23187 and Br-
X537A, indicate marked irregularities in the regulation of
transmembrane Ca2+ fluxes and insulin release by these
tumour cells. Interestingly, this is not the only observation
indicating either lack of effect of calcium ionophores or
general disturbances of Ca2+ metabolism in cancer cells
(Cittadini et al., 1981; Durham & Walton, 1982; Ralph,
1983).
Despite the failure of the tumours to respond as normal
insulin secreting cells to nutrients, calcium antagonists and
calcium ionophores, all three tumours exhibited evidence of
stimulated insulin release in the presence of theophylline.
This drug is an established inhibitor of cyclic AMP phospho-
diesterase and potentiates insulin secretion through elevation
of cyclic AMP without affecting intracellular Ca2+
(Roseman & Abrahamsson, 1985). This suggests that these
tumours may be responsive to agents modulating insulin
secretion through the adenylate cyclase-cyclic AMP system
(see Lins & Effendic, 1979), but as demonstrated by Veroni
and colleagues (1980) this may not correlate with the
apparent responsiveness of such tumours in vivo.
In conclusion, the present study has made a detailed
investigation of the regulation of transmembrane Ca2+
fluxes and insulin release in three benign functional
medullary-type insulinomas obtained at surgery. The results
suggest that inappropriate secretion of insulin from these
tumours is associated with, and possibly stems from marked
abnormalities in the regulation of voltage-gated Ca2+
channels in the B-cell plasma membrane.
These studies were supported by a grant from the Cancer Research
Campaign (SP 1630). We are grateful to Mr P.S. Boulter and
Professor I. McColl for assistance in obtaining the tumours.
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